Tin t&#x1EE9;c &amp; C&#x1EAD;p nh&#x1EAD;t

Patients with self-reported statin intolerance may benefit from proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors, which have been shown to lower atherogenic lipid markers in this population, suggests a recent study.

PCSK9 Inhibitor well tolerated in patients with statin intolerance

Vitamin D deficiency tied to hypertension

Low serum levels of 25-hydroxyvitamin D appear to be a risk factor for hypertension, a recent study has shown.

Vitamin D deficiency tied to hypertension

Treatment differs between HFrEF patients with vs without AF

Atrial fibrillation (AF) appears to be relatively common among patients with heart failure with reduced ejection fraction (HFrEF) and affects the prescription of guideline-recommended HF therapies, a recent study has shown.

Treatment differs between HFrEF patients with vs without AF

Per-pregnancy assessment of hypertensive disorder miscalculates number of affected women

The population-based incidence of hypertensive disorders of pregnancy (HDP) expressed as per-pregnancy underestimates the number of affected women during their reproductive years, according to a study. HDP history significantly increases the risks for future chronic conditions and multimorbidity.

Per-pregnancy assessment of hypertensive disorder miscalculates number of affected women

Dual trumps triple therapy in reducing bleeding risk in patients with AF post-PCI

15 May 2020 bởi

In adults with atrial fibrillation (AF) after percutaneous coronary intervention (PCI), dual therapy (direct oral anticoagulant [DOAC] + P2Y12 inhibitor) reduces the risk of bleeding compared with triple therapy (vitamin K antagonist [VKA] + DAPT* [aspirin and P2Y12 inhibitor]), a meta-analysis has shown. However, its effects on the risks of mortality and ischaemic endpoints** remain unclear.

Dual trumps triple therapy in reducing bleeding risk in patients with AF post-PCI

Slow walking pace a telltale sign for stroke in seniors

Older adults who walk slowly appear to have an excess risk of stroke as compared with their peers who have an average walking pace, according to a recent study.

Slow walking pace a telltale sign for stroke in seniors

Evolocumab plus statin delivers no impact on cognition

Evolocumab added to maximally tolerated statin therapy does not improve the cognitive performance of patients, even those who have achieved low-density lipoprotein cholesterol (LDL-C) levels <20 mg/dl, a recent study has shown.

Evolocumab plus statin delivers no impact on cognition

Cigarette smoking ups risk of masked daytime ambulatory, evening home hypertension

Cigarette smoking appears to elevate the risk of masked daytime ambulatory and evening home hypertension, reveals a recent study. This association is more pronounced among heavy smokers or older men.

Cigarette smoking ups risk of masked daytime ambulatory, evening home hypertension